Training on handling, storing and transporting Pfizer-BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran)

Overview

This training provides information on characteristics of different formulations of Pfizer-BioNTech COVID-19 vaccine, and procedures for effective management of the vaccine during storage, transport and use. It also includes guidance for establishing an ultra-cold chain system. It is recommended to select the appropriate slides/modules based on the training needs and profile of the participants.

The training slide set is organized in 16 modules:

  • Module 1: Product overview: Pfizer-BioNTech COVID-19 vaccine/COMIRNATY®
  • Module 2: Packaging and labeling information
  • Module 3: Monitoring vaccine expiration date and shelf life
  • Module 4: WHO guidance on off-label use of vaccines
  • Module 5: Vaccination schedule based on WHO SAGE recommendations
  • Module 6: Operational considerations on vaccine management and administration
  • Module 7: Shipping and vaccine arrival procedures
  • Module 8: Recommended vaccine deployment strategies
  • Module 9: Orientation on thermal shipping containers
  • Module 10: Orientation on temperature data loggers
  • Module 11: Equipment options for storing vaccines at ultra-low temperature
  • Module 12: Orientation on Ultra-low temperature (ULT) freezers and selection criteria
  • Module 13: Ultra-cold chain (UCC) system readiness
  • Module 14: Options for transporting ULT frozen vaccines to subnational stores
  • Module 15: Options for transporting and storing vaccines at lower-level stores and service points
  • Module 16: Managing vaccine storage and transport at service points

This material has been updated in all languages: version 15 February 2024.

First publication date 4 August 2021. Updated on 15 April 2022, 7 July 2022, 3 October 2022, 23 December 2022, 20 January 2023, 7 February 2023, August 2023, and September 2023.

Latest update: 15 February 2024

WHO Team
COVAX
Number of pages
139